1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Turner Syndrome Global Clinical Trials Review, H2, 2015

Turner Syndrome Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 81 pages

Turner Syndrome Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Turner Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Turner Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Turner Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Turner Syndrome Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Turner Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Turner Syndrome to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Turner Syndrome to Genetic Disorders Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Turner Syndrome 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Turner Syndrome Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Novo A/S 30
Clinical Trial Overview of Novo A/S 30
Eli Lilly and Company 31
Clinical Trial Overview of Eli Lilly and Company 31
E. Merck KG 32
Clinical Trial Overview of E. Merck KG 32
Ferring International Center S.A. 33
Clinical Trial Overview of Ferring International Center S.A. 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Orifarm Group A/S 35
Clinical Trial Overview of Orifarm Group A/S 35
LG Life Sciences, Ltd. 36
Clinical Trial Overview of LG Life Sciences, Ltd. 36
Ipsen S.A. 37
Clinical Trial Overview of Ipsen S.A. 37
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Dong-A Socio Group 39
Clinical Trial Overview of Dong-A Socio Group 39
Clinical Trial Overview of Top Institutes / Government 40
Eunice Kennedy Shriver National Institute of Child Health and Human Development 40
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 40
Aarhus University 41
Clinical Trial Overview of Aarhus University 41
National Institute of Neurological Disorders and Stroke 42
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 42
Hillerod Hospital 43
Clinical Trial Overview of Hillerod Hospital 43
Nemours Children's Clinic 44
Clinical Trial Overview of Nemours Children's Clinic 44
NHS Greater Glasgow and Clyde 45
Clinical Trial Overview of NHS Greater Glasgow and Clyde 45
Radboud University Nijmegen Medical Centre 46
Clinical Trial Overview of Radboud University Nijmegen Medical Centre 46
Rush University Medical Center 47
Clinical Trial Overview of Rush University Medical Center 47
Thomas Jefferson University 48
Clinical Trial Overview of Thomas Jefferson University 48
University Hospital Tubingen 49
Clinical Trial Overview of University Hospital Tubingen 49
Five Key Clinical Profiles 50
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81

List of Tables
Turner Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7
Turner Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Turner Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Turner Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Turner Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Turner Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Turner Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Turner Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Turner Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Turner Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Turner Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Turner Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Turner Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Turner Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Turner Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Turner Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Turner Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 30
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 31
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 32
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 33
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Orifarm Group A/S, 2015* 35
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2015* 36
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 37
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 38
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong-A Socio Group, 2015* 39
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 40
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 41
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2015* 42
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillerod Hospital, 2015* 43
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Nemours Children's Clinic, 2015* 44
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2015* 45
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2015* 46
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2015* 47
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015* 48
Turner Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2015* 49

List of Figures
Turner Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Turner Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Turner Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Turner Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Turner Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Turner Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Turner Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Turner Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Turner Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Turner Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Turner Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Turner Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Turner Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Turner Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Turner Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.